LETTER TO THE EDITOR
Weakened humoral immune responses of inactivated SARS-CoV-2 vaccines in patients with solid tumors
Zhiwei Chen, Peng Zhu, Zuojin Liu, Bin Zhu, Guobing Yin, Jia Ming, Rui Song, Qingbo Pan, Tong Li, Xingwei Jiang, Bing Wang, Shuaibin Liu, Hongxing Cai, Jingjie Wang, Yuling Han, Zijing Lin, Yang Hong, Min Chen, Mingli Peng, Lina Hu, Dachuan Cai, Hong Ren
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/4/2022 doi:10.1002/cac2.12368
ORIGINAL ARTICLE
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non-small-cell lung cancer characterizes the features of response to PD-1 blockade plus chemotherapy
Fengying Wu, Tao Jiang, Gongyan Chen, Yunchao Huang, Jianying Zhou, Lizhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/4/2022 doi:10.1002/cac2.12383
LETTER TO THE EDITOR
A phase Ib/II study of fruquintinib in combination with paclitaxel as the second-line therapy for advanced gastric cancer
Yang Zhang, Zi-Xian Wang, Lin Shen, Jin Li, Jing Huang, Wei-Guo Su, Dong-Sheng Zhang, Rui-Hua Xu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/4/2022 doi:10.1002/cac2.12379
ORIGINAL ARTICLE
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
Yufei Yang, Dakui Luo, Yang Shao, Zezhi Shan, Qi Liu, Junyong Weng, Weijing He, Ruoxin Zhang, Qingguo Li, Ziliang Wang, Xinxiang Li
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/3/2022 doi:10.1002/cac2.12380
REVIEW
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
Hang Yang, Xinyi Zhou, Dongliang Fu, Chenqin Le, Jiafeng Wang, Quan Zhou, Xiangrui Liu, Ying Yuan, Kefeng Ding, Qian Xiao
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/31/2022 doi:10.1002/cac2.12377
ORIGINAL ARTICLE
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessment
Chen-hua Yan, Yu Wang, Yu-qian Sun, Yi-fei Cheng, Xiao-dong Mo, Feng-rong Wang, Yu-hong Chen, Yuan-yuan Zhang, Ting-ting Han, Huan Chen, Lan-ping Xu, Xiao-hui Zhang, Kai-yan Liu, Xiao-jun Huang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/23/2022 doi:10.1002/cac2.12376
REVIEW
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, Shengfang Ge, Peiwei Chai, Ai Zhuang, Xianqun Fan
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/20/2022 doi:10.1002/cac2.12374
ORIGINAL ARTICLE
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
Huanwen Wu, Zicheng Yu, Yueping Liu, Lei Guo, Lianghong Teng, Lingchuan Guo, Li Liang, Jing Wang, Jie Gao, Ruiyu Li, Ling Yang, Xiu Nie, Dan Su, Zhiyong Liang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/20/2022 doi:10.1002/cac2.12372
REVIEW
The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
Amandine Crombé, Mathtieu Roulleau-Dugage, Antoine Italiano
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/19/2022 doi:10.1002/cac2.12373
LETTER TO THE EDITOR
Social-epigenetic mediators for racial disparities in pulmonary impairment among childhood cancer survivors
Nan Song, Qian Dong, Cheng Chen, Qian Li, Heather Mulder, Emily Plyler, John Easton, Emily Walker, Scott Olson, Geoffrey Neale, Kevin R. Krull, Deo Kumar Srivastava, Kirsten K. Ness, Jinghui Zhang, Melissa M. Hudson, Leslie L. Robison, I-Chan Huang, Zhaoming Wang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/18/2022 doi:10.1002/cac2.12371
